Found 321 articles
DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced the company has become a member of The Skin Cancer Foundation Corporate Council.
Immune Pharmaceuticals Inc. is in early-stage discussions with United General LTD, a UK Institutional Investment firm. Immune Pharmaceuticals Incs trustee and representatives are exploring options to restructure the company with United General LTD.
Purdue Pharma L.P. filed a Chapter 11 plan of reorganization and a related disclosure statement in the United States Bankruptcy Court for the Southern District of New York.
BioRestorative Therapies, Inc., a life sciences company focused on stem cell-based therapies, announced that its amended joint plan of reorganization has become effective and it has emerged from Chapter 11 reorganization.
In partnership with renowned imaging research center, Neuro42 to commercialize technology that helps physicians triage patients with neurological diseases and injuries sooner
Pharmaceutical Giant Mallinckrodt Bankruptcy Threatens Lawsuit Filed by Local Unions and Delaware Valley Health Care Coalition, Worth Hundreds of Millions of Dollars
In response to the pharmaceutical giant Mallinckrodt’s bankruptcy filing last week, Delaware Valley Health Care Coalition, Inc. (DVHCC) President John Heenan said, “Its crucial for our members to have a seat at the table for the bankruptcy proceedings.” The DVHCC is a non-profit voluntary association comprised of multi-employer trust funds, governmental entities, labor unions, schools and school districts in ov
Mallinckrodt plc announced that it has received approvals from the U.S. Bankruptcy Court for the District of Delaware for its "First Day" motions related to the Company' s voluntary Chapter 11 petitions filed on October 12, 2020.
Aesculap, Inc., an industry leader in sterile processing and operating room solutions, is pleased to announce its strategic partnership with Ascendco Health, an emerging health tech company.
Mallinckrodt has filed for Chapter 11 bankruptcy amid growing lawsuits that allege the company has participated in fueling the opioid epidemic in the United States.
Mallinckrodt Secures Broad Consensus with Key Stakeholders on Comprehensive Chapter 11 Restructuring
Mallinckrodt plc announced that it has voluntarily initiated Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware to modify its capital structure, including restructuring portions of its debt, and resolve several billion dollars of otherwise unmanageable potential legal liabilities.
Company positioned to enter its next phase of growth with new ownership and a more sustainable capital structure
Akorn, Inc., a leading specialty pharmaceutical company, announced that the United States Bankruptcy Court for the District of Delaware has approved its sale to the Company's existing lenders.
VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC
VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced that it has completed the solicitation of an in-court prepackaged plan of reorganization, under which IEH Biopharma LLC (“IEH”) will take 100% ownership of VIVUS (the “Prepackaged Plan”), ahead of its July 7, 2020 chapter 11 filing.
Two years after Germany’s Fresenius Medical Care walked away from a 2017 $4.3 billion deal to acquire Akorn Pharmaceuticals, the company has filed for protection under U.S. bankruptcy laws as it attempts to restructure for a potential sale.
Continues Operations as Usual, Delivering Safe and Effective Products to Customers and Patients
Sophiris Bio Inc., announced that its board of directors has formally approved an immediate shutdown of the operations of the Company.
Several recent articles inaccurately state an affiliation between Rising Pharma Holdings, Inc., and Rising Pharmaceuticals, Inc., and its parent company, ACETO Corporation.
Deerfield Management placed Melinta’s assets up for auction, but no other companies made competing bids, leaving Deerfield in control of the company’s assets.
Mallinckrodt Files Chapter 11 for its Generics Business as it Reaches $1.6 Billion Opioid Settlement
2/25/2020In addition to the settlement and bankruptcy, Mallinckrodt entered into a debt refinancing agreement, including an $800 million loan that will be used to repay some outstanding debt and acquire some outstanding stocks.
Purdue Taps Tom Vilsack, Former Cabinet Secretary and Governor, to Monitor Compliance With Voluntary Injunction
Feb. 21, 2020 15:13 UTC STAMFORD, Conn.--( BUSINESS WIRE )-- Purdue Pharma L.P. (“Purdue”) today announced the appointment of former United States Agriculture Secretary and Iowa Governor Tom Vilsack as Monitor under the voluntary self-injunction approved on November 6, 2019, in its chapter 11 bankruptcy case. In its initial bankruptcy filings, Purdue voluntarily proposed to formalize under court order its commitment to continue to refrain from engaging in certain promotional